Status:
COMPLETED
SCOSI-M: Preventing Prescription Drug Problems
Lead Sponsor:
Brandeis University
Collaborating Sponsors:
University of South Carolina
Medical University of South Carolina
Conditions:
Prescription Drug Problems
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Brandeis University and University of South Carolina (USC) have joined together to develop the South Carolina Opioid Safety Initiative - Military (SCOSI-M), to develop an academic detailing (medical e...
Eligibility Criteria
Inclusion
- a physician within one of the 3 practice environments;
- typically prescribes Schedule II opioids to 10 or more non-cancer pain patients each month;
- if community office-based, a substantial number of patients must have TRICARE (e.g., 20%); and d) willing to provide written consent for data collection and release of own SCRIPTS data.
Exclusion
- non-physician providers who report data to the SCRIPTS (dentist, veterinarians, nurses),
- surgeons, pediatricians, or physicians predominately treating pain in cancer or surgical patients, and,
- not eligible to register as authorized SCRIPTS user.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2019
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT02210936
Start Date
July 1 2014
End Date
May 1 2019
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brandeis University
Waltham, Massachusetts, United States, 02454